Back

Elevated remnant cholesterol confers high risk of ASCVD without prompting lipid-lowering therapy: an unmet medical need

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Lipids (1) Lipids ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Karen Hvid

Herlev Hospital, Herlev (Denmark)

7 More presentations in this session

Presentation thumbnail
The effect of baseline low-normal insulin-like growth factor-1 on the relation between lipoprotein (a) and incident type 2 diabetes and outcome: observations from the UK-Biobank.
Doctor J. Sangha (Cambridge, GB)
Abstract Slides Video
Presentation thumbnail
Project on lipid profile optimization in very high cardiovascular risk patients through a virtual lipid unit in our city healthcare area
Doctor L. Villafafila (Toledo, ES)
Abstract Slides Video
Presentation thumbnail
Validation of the familial hypercholesterolemia diagnosis in the Danish National Patient Registry and the Danish familial hypercholesterolemia registry
Doctor J. Knold (Odense, DK)
Abstract Slides Video
Presentation thumbnail
Discordance in the measurement of Achilles tendon thickness between soft X-ray radiography and ultrasonography among patients with coronary artery disease
Doctor T. Itagaki (Matsumoto, JP)
Abstract Slides Video
Presentation thumbnail
Elevated triglycerides are related to higher residual cardiovascular disease and mortality risk independent of lipid targets and lipid-lowering therapy intensity in cardiovascular disease patients
Miss P. Schuitema (Utrecht, NL)
Abstract Slides Video

Access the full session

Session thumbnail
Lipids (1)

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Remnant cholesterol lowering in cardiovascular disease risk reduction in statin trials: meta-regression analyses
thumbnail
Congress Presentation
Remnant cholesterol is a predictor for all-cause mortality in coronary artery disease patients independent of the total ApoB-particle count
thumbnail
Congress Presentation
Lipoprotein(a) cardiovascular disease risk not captured by low density lipoprotein cholesterol and apolipoprotein B

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources